OncoC4 has a total of 151 patents globally, out of which 54 have been granted. Of these 151 patents, more than 85% patents are active. United States of America is where OncoC4 has filed the maximum number of patents, followed by China and Europe (EPO). Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of OncoC4.
OncoC4 founded in 2020 and based in Rockville, Maryland, OncoC4 is a privately held, late-stage biopharmaceutical company focused on developing novel biologics for cancer treatment. Its lead candidate, BNT316/ONC-392, is a next-generation anti-CTLA-4 antibody designed to enhance anti-tumor response while preserving immune regulation. OncoC4 also has a pipeline targeting the CD24-Siglecs immune evasion pathway, aiming to develop first-in-class cancer therapies.
Do read about some of the most popular patents of OncoC4 which have been covered by us in this article and also you can find OncoC4 patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over OncoC4 patent portfolio.
How many patents does OncoC4 have?
OncoC4 has a total of 151 patents globally. These patents belong to 20 unique patent families. Out of 151 patents, 128 patents are active.
How Many Patents did OncoC4 File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | OncoC4 Applications Filed | OncoC4 Patents Granted |
| 2025 | 1 | 7 |
| 2024 | 17 | 16 |
| 2023 | 21 | 8 |
| 2022 | 21 | 3 |
| 2021 | 5 | 11 |
| 2020 | 6 | 1 |
| 2019 | 26 | 2 |
| 2018 | 3 | 2 |
| 2017 | 7 | 1 |
| 2016 | 27 | 2 |
How many OncoC4 patents are Alive/Dead?
Worldwide Patents
How Many Patents did OncoC4 File in Different Countries?
Countries in which OncoC4 Filed Patents
| Country | Patents |
| United States of America | 19 |
| China | 12 |
| Europe (EPO) | 11 |
| Mexico | 9 |
| Australia | 9 |
| Canada | 8 |
| Singapore | 8 |
| Hong Kong (S.A.R.) | 7 |
| Taiwan | 5 |
| New Zealand | 5 |
| Israel | 5 |
| Brazil | 3 |
| India | 3 |
| Poland | 2 |
| Albania | 2 |
| Denmark | 2 |
| Macao | 2 |
| Lithuania | 2 |
| Portugal | 2 |
| Hungary | 2 |
| Slovenia | 2 |
| Spain | 2 |
| Malta | 2 |
| Norway | 2 |
| Cyprus | 1 |
| Serbia | 1 |
| Finland | 1 |
| Colombia | 1 |
| Chile | 1 |
| Indonesia | 1 |
| Croatia | 1 |
| Germany | 1 |
| Russia | 1 |
| South Africa | 1 |
| Malaysia | 1 |
| Former Yugoslav Republic of Macedonia | 1 |
| Slovakia | 1 |
| Estonia | 1 |
| Italy | 1 |
Where are Research Centres of OncoC4 Patents Located?
10 Best OncoC4 Patents
US10618960B2 is the most popular patent in the OncoC4 portfolio. It has received 13 citations so far from company like Kashiv Biosciences Llc.
Below is the list of 10 most cited patents of OncoC4:
| Publication Number | Citation Count |
| US10618960B2 | 13 |
| US20210047410A1 | 5 |
| US11261233B2 | 4 |
| CN112135632A | 4 |
| CN116942793A | 2 |
| US20220259286A1 | 2 |
| CA3099554A1 | 2 |
| US12227557B2 | 1 |
| WO2023077069A1 | 1 |
| CN111699195A | 1 |
What Percentage of OncoC4 US Patent Applications were Granted?
OncoC4 (Excluding its subsidiaries) has filed 18 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 7 have been granted leading to a grant rate of 58.33%.
Below are the key stats of OncoC4 patent prosecution at the USPTO.
Which Law Firms are managing US Patents for OncoC4?
| Law Firm | Total Applications | Success Rate |
| Polsinelli Pc | 17 | 58.33% |
| Nevrivy Patent Law Group Pllc | 1 | 0% |
What are OncoC4 key innovation segments?
What Technologies are Covered by OncoC4?
The chart below distributes patents filed by OncoC4 in different countries on the basis of the technology protected in patents. It also represents the markets where OncoC4 thinks it’s important to protect particular technological inventions.
R&D Focus: How has OncoC4 search focus changed over the years?
EXCLUSIVE INSIGHTS COMING SOON!
Interested in knowing about the areas of innovation that are being protected by OncoC4?
